LENZ Therapeutics, Inc. (LENZ)

5.96 +0.13 (+2.23%) USD  |  NASDAQ  |  Sep 04, 16:00
5.965 0.00 (0.00%) After-Hours: 20:00
More

LENZ Therapeutics EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for LENZ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical EPS LT Growth Estimates Data

View and export this data back to 2024. Start Trial.
Date Value
November 06, 2024 --
Date Value
August 14, 2024 --

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Impact BioMedical, Inc. --
Enveric Biosciences, Inc. --
Ocular Therapeutix, Inc. Upgrade
Liquidia Corp. --
Aquestive Therapeutics, Inc. --